Purchase Order HHSD2002016M90217P

This is a Small Business Innovation Research (SBIR) Phase 1 contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Kephera Diagnostics LLC, a small business. The contract is for the development of diagnostics to detect taeniasis, a parasitic infection, in order to prevent neurocysticercosis and associated epilepsy. The award amount is $150,000.00 and the contract has a firm fixed price pricing type. The contract was set aside...

Immuno Mycologies Inc. was awarded a $299,593 firm fixed price definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop an easy-to-use diagnostic test capable of early, rapid detection of Talaromyces antigen in human serum, plasma, and/or urine. This contract was awarded under the Small Business Innovation Research Program Phase I solicitation issued by NIH and the Centers for Disease Control and Prevention seeking proposals to...

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation). The contract, with a ceiling value of $272,866.00, is for the "PRODUCTION AND DISTRIBUTION OF ACANTHOCHEILONEMA VITEAE REAGENTS." The contract is a Delivery Order under the NIAID Animal Models of Infectious Diseases 2010-2017 indefinite...

This federal contract award, with the ID HHSN272201000653P, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Mimotopes Inc., a for-profit manufacturer of goods, on June 11, 2010. The $11,344.00 firm fixed-price purchase order is for the delivery of a "TAS::75 0885::TAS RECOVERY ACT PEPSET PEPTIDE LIBRARY>5 UMOL, W SOLUBILITY INFO" and has a completion date of July 9, 2010. The contract is not set aside for any specific business type. This award...

This is a cost-no-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to the American Foundation For Biological Research (doing business as Biomedical Research Institute), a non-profit organization. The $523,459 contract is for the maintenance, development, and production of schistosomiasis parasites, reagents, and assays, which supports the NIAID's research on...

The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $989,300.00 Firm Fixed Price Definitive Contract to Aptagen LLC, a for-profit limited liability company, to provide SBIR Phase II funding for finding human carriers of taeniasis to prevent neurocysticercosis associated epilepsy. The contract, which does not have a set-aside designation, was awarded on September 30, 2019 with a completion date of September 29, 2021. Aptagen LLC has over...

This is a $6,325,163.04 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMMS) for a project titled "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract does not have a set-aside designation. The objective is to conduct research to identify T-cell epitopes of pathogenic fungi including Blastomyces, Coccidioides, Cryptococcus, and...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $22,595,588.82 cost-plus-fixed-fee definitive contract to Versatope Therapeutics Inc., a for-profit biotechnology company based in Lowell, Massachusetts. This contract, awarded under the HHS-NIH-NIAID-BAA2018 program, supports research to establish and improve biomedical knowledge on infectious diseases such as malaria. The contract has an ultimate completion date of June 28, 2025....

This federal contract award to Immuno Mycologies Inc., a small business manufacturer of diagnostic products, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $1,499,709 firm fixed-price contract is for the development and validation of an enzyme immunoassay (EIA) to detect the Talaromyces marneffei antigen, which causes the fungal disease talaromycosis. This is a Phase II Small Business Innovation Research...

The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $59,541 firm fixed price purchase order to Genscript USA Inc. to provide customized antibody synthesis, expression, purification, and plasmid preparations in support of the Laboratory of Malaria Immunology and Vaccinology's (LMIV) malaria vaccine research. Per the original solicitation, LMIV requires custom monoclonal antibodies that can label and sort immune cell subsets in its colony...